Why the study?
The role of CMR imaging in guiding interventions and risk stratification for outcomes in aortic regurgitation remained to be fully defined.
Does cardiovascular magnetic resonance (CMR)-derived aortic regurgitation fraction (ARF) > 33% predict adverse clinical outcomes and intervention timing in patients with aortic regurgitation?
Does cardiovascular magnetic resonance (CMR)-derived aortic regurgitation fraction (ARF) > 33% predict adverse clinical outcomes and intervention timing in patients with aortic regurgitation?
CMR-derived aortic regurgitation fraction > 33% is strongly predictive of adverse clinical outcomes and can help guide intervention timing in patients with aortic regurgitation.
Answers are grounded in this paper and cite their sources.
Supports CMR ARF >33% for AR intervention timing decisions; confirms prognostic value in meta-analysis.
AIMS: Aortic regurgitation (AR) is a prevalent valvular disease. Cardiovascular magnetic resonance (CMR) imaging is emerging as an accurate and precise method for assessing AR. However, its role in guiding interventions and risk stratification for outcomes remains to be fully defined. OBJECTIVE: This systematic review and meta-analysis evaluate the predictive utility of CMR-derived AR fraction (ARF) in determining intervention timing and clinical outcomes. METHODS AND RESULTS: A systematic search identified observational studies assessing CMR-derived ARF in AR prognostication. Hazard ratios (HRs) for intervention timing, mortality, and heart failure were pooled using a random-effects model. Study heterogeneity (I² statistic) was assessed, and publication bias was evaluated using a funnel plot. A total of 1235 studies were screened, with 12 meeting the inclusion criteria. Eight studies (n = 1996 patients) were included in the meta-analysis. ARF severity thresholds ranged from 30 to 43% (mean 33.7%). Follow-up ranged from 2 to 5.1 years. The pooled HR for clinic outcomes with an ARF > 33% was 4.12 (95% CI: 2.31-7.34, P value < 0.01). The highest reported HR was 24.59, while the lowest was 1.04. Studies demonstrated that a higher ARF correlates with an increased risk of adverse outcomes, supporting CMR as a key tool for risk stratification and intervention timing. CONCLUSION: CMR-derived ARF is strongly predictive of clinical outcomes. ARF > 33% is associated with significantly increased risk, warranting its integration into clinical decision-making frameworks.
No takes yet. Share an insight, caveat, or question.
Bali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: